WO2007112025A3 - Composite vascular prosthesis - Google Patents

Composite vascular prosthesis Download PDF

Info

Publication number
WO2007112025A3
WO2007112025A3 PCT/US2007/007299 US2007007299W WO2007112025A3 WO 2007112025 A3 WO2007112025 A3 WO 2007112025A3 US 2007007299 W US2007007299 W US 2007007299W WO 2007112025 A3 WO2007112025 A3 WO 2007112025A3
Authority
WO
WIPO (PCT)
Prior art keywords
prosthesis
composite
passivate
bioactive
vascular prosthesis
Prior art date
Application number
PCT/US2007/007299
Other languages
French (fr)
Other versions
WO2007112025A2 (en
Inventor
Juan F Granada
Simon M Furnish
Original Assignee
Prescient Medical Inc
Juan F Granada
Simon M Furnish
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Prescient Medical Inc, Juan F Granada, Simon M Furnish filed Critical Prescient Medical Inc
Publication of WO2007112025A2 publication Critical patent/WO2007112025A2/en
Publication of WO2007112025A3 publication Critical patent/WO2007112025A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/507—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials for artificial blood vessels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/28—Materials for coating prostheses
    • A61L27/34—Macromolecular materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/54—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2250/00—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2250/0058—Additional features; Implant or prostheses properties not otherwise provided for
    • A61F2250/0067—Means for introducing or releasing pharmaceutical products into the body
    • A61F2250/0068—Means for introducing or releasing pharmaceutical products into the body the pharmaceutical product being in a reservoir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/252—Polypeptides, proteins, e.g. glycoproteins, lipoproteins, cytokines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
    • A61L2300/606—Coatings

Abstract

A novel treatment for atherosclerotic vascular disease is described utilizing the implantation of a thin, conformable biocompatible prosthesis constructed from a composite of various structural and therapeutic scaffolds in combination with one or more bioactive agents. This prosthesis can be delivered into position over a lesion in order to passivate atherosclerotic plaques with minimal remodeling of the artery, or alternatively can be applied with a balloon to passivate the remodeled site. The composite prosthesis itself provides mild structural reinforcement of the vessel wall and an evenly distributed platform for the introduction of bioactive therapeutic agents.
PCT/US2007/007299 2006-03-24 2007-03-23 Composite vascular prosthesis WO2007112025A2 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US78557906P 2006-03-24 2006-03-24
US60/785,579 2006-03-24
US85264306P 2006-10-19 2006-10-19
US60/852,643 2006-10-19

Publications (2)

Publication Number Publication Date
WO2007112025A2 WO2007112025A2 (en) 2007-10-04
WO2007112025A3 true WO2007112025A3 (en) 2008-03-20

Family

ID=38541693

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2007/007299 WO2007112025A2 (en) 2006-03-24 2007-03-23 Composite vascular prosthesis

Country Status (1)

Country Link
WO (1) WO2007112025A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2022525788A (en) 2019-03-20 2022-05-19 インキュベート メディカル テクノロジーズ、 エルエルシー Aortic dissection implant
CN113520685A (en) * 2021-08-03 2021-10-22 上海微创医疗器械（集团）有限公司 Stent for blood vessels

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6827732B2 (en) * 1999-09-23 2004-12-07 Ev3 Peripheral, Inc. Stent with enhanced friction
US20050181016A1 (en) * 2003-07-17 2005-08-18 Toby Freyman Decullularized extracellular matrix of conditioned body tissues and uses thereof
US20060020331A1 (en) * 2002-07-12 2006-01-26 Cook Incorporated Coated medical device

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6827732B2 (en) * 1999-09-23 2004-12-07 Ev3 Peripheral, Inc. Stent with enhanced friction
US20060020331A1 (en) * 2002-07-12 2006-01-26 Cook Incorporated Coated medical device
US20050181016A1 (en) * 2003-07-17 2005-08-18 Toby Freyman Decullularized extracellular matrix of conditioned body tissues and uses thereof

Also Published As

Publication number Publication date
WO2007112025A2 (en) 2007-10-04

Similar Documents

Publication Publication Date Title
WO2005097228A3 (en) Coating compositions for bioactive agents
WO2008005535A3 (en) Expandable vascular endoluminal prostheses
WO2009144580A3 (en) Coatings for promoting endothelization of medical devices
MX2009003921A (en) Omega-3 fatty acids and dyslipidemic agent for reduction of apo-b levels.
WO2007089544A3 (en) Biodegradable non-ophthalmic implants and related methods
WO2005077450A3 (en) Intravascular delivery system for therapeutic agents
WO2004098455A3 (en) Bifurcated medical appliance delivery apparatus and method
WO2005034852A3 (en) Protein biomaterials and biocoacervates and methods of making and using thereof
EP1779817A4 (en) Stent
WO2005051229A3 (en) Devices delivering therapeutic agents and methods regarding the same
WO2008073670A3 (en) Unit dose formulations and methods of treating thrombosis with an oral factor xa inhibitor
WO2008076548A3 (en) Cardiovascular procedures
WO2009134991A3 (en) Tissue engineered blood vessel
WO2003061731A3 (en) Methods and kits for delivering pharmaceutical agents into the coronary vascular adventitia
MX2010000549A (en) Composite implant for surgical repair.
EP3158866A3 (en) Use of neuromodulating agents for treating hypertension by local vascular delivery
WO2003009777A3 (en) Delivery of therapeutic capable agents
WO2011089620A3 (en) Method and insertable medical device for delivering one or more pro-healing agents to target site within blood vessel post-deployment of stent
WO2004058100A3 (en) Vascular prosthesis and methods of use
WO2006044509A3 (en) Methods of treating vascular injuries
HK1083469A1 (en) Biodegradable vascular device with buffering agent
WO2007105210A3 (en) Therapeutic uses of cannabidiol compounds
WO2009141732A3 (en) Polyurethane foam for use in medical implants
WO2009004995A1 (en) Method of fixing and expressing physiologically active substance
WO2006093860A3 (en) Method and composition for repairing heart tissue

Legal Events

Date Code Title Description
DPE2 Request for preliminary examination filed before expiration of 19th month from priority date (pct application filed from 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 07753889

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 07753889

Country of ref document: EP

Kind code of ref document: A2